WCG
NVO

Weaver Consulting Group’s Novo Nordisk NVO Stock Holding History

Weaver Consulting Group’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-368
Closed -$13K – 637
2020
Q3 		$13K Hold
368
– – 0.01% 493
2020
Q2 		$12K Buy
368
+58
+19% +$1.85K 0.01% 482
2020
Q1 		$9K Buy
310
+178
+135% +$5.3K 0.01% 469
2019
Q4 		$3K Hold
132
– – ﹤0.01% 692
2019
Q3 		$3K Hold
132
– – ﹤0.01% 677
2019
Q2 		$3K Hold
132
– – ﹤0.01% 665
2019
Q1 		$3K Buy
+132
New +$3.24K ﹤0.01% 1240

Other funds holding NVO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
EHC
Everett Harris & Co Los Angeles, California $7.77B AUM 9.43% 1-Year Est. Return

Weaver Consulting Group's NVO Position: Q4 2020 in Review

Weaver Consulting Group sold out of Novo Nordisk (NVO) in Q4 2020, closing a stake of 368 shares — an estimated $13K sold.

Weaver Consulting Group first reported a position in NVO in Q1 2019 and held it in 7 quarters. The position peaked at $13K in Q3 2020. 702 funds tracked by Wall St. Rank hold NVO as of Q4 2020.

  • Weaver Consulting Group reported no remaining Novo Nordisk position as of Q4 2020 after selling out during the quarter.
  • Weaver Consulting Group sold 368 Novo Nordisk shares in Q4 2020, an estimated $13K.
  • Weaver Consulting Group first reported a position in Novo Nordisk in Q1 2019 and held it in 7 quarters.
  • Weaver Consulting Group's Novo Nordisk position peaked at $13K in Q3 2020.
  • 702 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2020.

Based on Weaver Consulting Group's 13F filing for Q4 2020, filed 29 Jan 2021.